You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,454,996


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,454,996
Patent landscape, scope, and claims:
Title:Pharmaceutical composition for the treatment of acute disorders
Abstract: A pharmaceutical composition for the treatment of acute disorders is described. The composition comprises an essentially water-free, ordered mixture of at least one pharmaceutically active agent in the form of microparticles which are adhered to the surfaces of carrier particles which are substantially larger than the particles of the active agent or agents, and are essentially water-soluble, in combination with the bioadhesion and/or mucoadhesion promoting agent. The invention also relates to a method for preparing the composition and to the use of the composition for the treatment of acute disorders.
Inventor(s): Pettersson; Anders (Kode, SE), Nystrom; Christer (Lidingo, SE)
Assignee: Orexo AB (Uppsala, SE)
Application Number:13/302,694
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,454,996
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,454,996

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,454,996

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9803240Sep 24, 1998

International Family Members for US Patent 8,454,996

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2236132 ⤷  Subscribe C300714 Netherlands ⤷  Subscribe
European Patent Office 2236132 ⤷  Subscribe CA 2015 00004 Denmark ⤷  Subscribe
European Patent Office 2236132 ⤷  Subscribe 92636 Luxembourg ⤷  Subscribe
European Patent Office 2236132 ⤷  Subscribe 122015000006 Germany ⤷  Subscribe
European Patent Office 2236132 ⤷  Subscribe 484 Finland ⤷  Subscribe
European Patent Office 2236132 ⤷  Subscribe 300714 Netherlands ⤷  Subscribe
Austria 365540 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.